FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology, and can be used for treating upper extremity tremor. A patient is injected with a botulinum neurotoxin in 4, 5, 6 or 7 muscles of the forearm/wrist selected from a group M. extensor carpi ulnaris (ECU), M. extensor carpi radialis (ECR), M. pronator quadratus (PQ), M. supinator in dosage from 2.5 units ±10% up to 5 units ±10%, M. flexor carpi radialis (FCR), M. flexor carpi ulnaris (FCU), M. pronator teres (PT) in dosage from 5 units ±10% up to 15 units ±10%, 2 muscles of elbow M. Brachialis and M. triceps brachii in dosage of 20 units ±10 % and 4 shoulder muscles M. latissimus dorsi, M. pectoralis major, M. supraspinatus and M. infraspinatus in dosage 15 units ±10% per muscle.
EFFECT: method provides treating upper extremity tremor by administering botulinum neurotoxin into muscles of each forearm/wrist, elbow and shoulder.
14 cl, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AND COSMETIC USE OF SEROTYPE E NEUROTOXIN BOTULINUM | 2019 |
|
RU2800604C2 |
| ENGINEERED BOTULINUM NEUROTOXIN | 2016 |
|
RU2746736C2 |
| CONSTRUCTED BOTULINUM NEUROTOXIN | 2017 |
|
RU2789302C2 |
| METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES | 2018 |
|
RU2719164C1 |
| METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES | 2019 |
|
RU2727402C1 |
| HYBRID NEUROTOXINS | 2017 |
|
RU2782382C2 |
| SINGLE-DOMAIN ANTIBODY AND ITS MODIFICATIONS SPECIFICALLY BINDING TO BOTULINUM NEUROTOXIN TYPE A, AND METHOD OF USING THEM FOR THERAPY OR EMERGENCY PREVENTION OF INTOXICATION CAUSED BY BOTULINUM NEUROTOXIN TYPE A | 2021 |
|
RU2766348C1 |
| COMPLEX, AGENT AND APPLICATION OF TYPE A BOTULINUM TOXIN CLOSTRIDIUM BOTULINUM | 2020 |
|
RU2783511C1 |
| BOTULINUM NEUROTOXIN BIOHYBRID | 2019 |
|
RU2816855C2 |
| COMBINED COMPOSITION CONTAINING FGF-18 COMPOUND | 2016 |
|
RU2745453C2 |
